Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2008 | 10-2007 | 12-2006 | 10-2006 | 12-2005 | |
| Sales | 1,442,600 | 1,276,700 | 0 | 1,231,900 | 0 |
| Cost of Goods | 961,300 | 834,100 | N/A | 825,600 | N/A |
| Gross Profit | 481,300 | 442,600 | N/A | 406,300 | N/A |
| Operating Expenses | 414,900 | 364,700 | 0 | 361,700 | 0 |
| Operating Income | 66,700 | 78,000 | N/A | 45,200 | N/A |
| Other Income | -100,600 | 48,800 | 0 | 10,400 | 0 |
| Pre-tax Income | -33,900 | 126,800 | 0 | 55,600 | 0 |
| Income Tax | 6,200 | 3,300 | N/A | -37,700 | N/A |
| Net Income Continuous | -40,100 | 123,500 | N/A | 93,300 | N/A |
| Net Income Discontinuous | -2,500 | -17,200 | N/A | -28,200 | N/A |
| Minority Interests | -700 | N/A | N/A | N/A | N/A |
| Net Income | $-41,900 | $106,300 | $N/A | $65,700 | $N/A |
| EPS Basic Total Ops | -0.36 | 0.91 | N/A | 0.56 | N/A |
| EPS Basic Continuous Ops | -0.34 | 1.05 | N/A | 0.80 | N/A |
| EPS Basic Discontinuous Ops | -0.02 | -0.14 | N/A | -0.25 | N/A |
| EPS Diluted Total Ops | -0.36 | 0.91 | N/A | 0.56 | N/A |
| EPS Diluted Continuous Ops | -0.34 | 1.04 | N/A | 0.79 | N/A |
| EPS Diluted Discontinuous Ops | -0.02 | -0.13 | N/A | -0.24 | N/A |
| EBITDA(a) | $153,300 | $147,500 | $N/A | $114,000 | $N/A |